ONTOLOGY REPORT - ANNOTATIONS
| Term: | dichlorvos |
|
| Accession: | CHEBI:34690
|
browse the term
|
| Definition: | An alkenyl phosphate that has formula C4H7Cl2O4P. |
| Synonyms: | related_synonym: | 2,2-Dichloroethenyl dimethyl phosphate; C4H7Cl2O4P; COP(=O)(OC)OC=C(Cl)Cl; DDVP; Dimethyl 2,2-dichlorovinyl phosphate; InChI=1S/C4H7Cl2O4P/c1-8-11(7,9-2)10-3-4(5)6/h3H,1-2H3; InChIKey=OEBRKCOSUFCWJD-UHFFFAOYSA-N; Phosphoric acid, 2,2-dichloroethenyl dimethyl ester; Phosphoric acid, 2,2-dichlorovinyl dimethyl ester |
| | xref_casrn: | 62-73-7 |
| | xref: | Beilstein:1709141 "Beilstein Registry Number"; ChEMBL:378091 "ChEMBL COMPOUND"; ChemIDplus:62-73-7 "CAS Registry Number"; KEGG COMPOUND:62-73-7 "CAS Registry Number"; KEGG COMPOUND:C14430 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D004006 |
| | xref: | NIST Chemistry WebBook:62-73-7 "CAS Registry Number"; Wikipedia:Dichlorvos "Wikipedia" |
|
|
dichlorvos
|
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
increases phosphorylation |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
increases phosphorylation |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
increases acylation |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases response to substance |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
EXP |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
decreases activity |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
AKR7A3 |
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
increases expression |
ISO |
1 |
19,609,057 |
19,615,280 |
RGD:6480464 |
CTD |
| G |
ALB |
albumin |
|
affects binding |
EXP |
4 |
74,269,972 |
74,287,129 |
RGD:6480464 |
CTD |
| G |
ALB |
albumin |
|
affects binding |
EXP |
4 |
74,269,972 |
74,287,129 |
RGD:6480464 |
CTD |
| G |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
9 |
75,515,578 |
75,568,233 |
RGD:6480464 |
CTD |
| G |
ANXA2 |
annexin A2 |
|
increases expression |
ISO |
15 |
60,639,350 |
60,690,185 |
RGD:6480464 |
CTD |
| G |
APEH |
N-acylaminoacyl-peptide hydrolase |
|
decreases activity |
EXP |
3 |
49,711,435 |
49,720,934 |
RGD:6480464 |
CTD |
| G |
APEH |
N-acylaminoacyl-peptide hydrolase |
|
decreases activity |
ISO |
3 |
49,711,435 |
49,720,934 |
RGD:6480464 |
CTD |
| G |
APEH |
N-acylaminoacyl-peptide hydrolase |
|
decreases activity |
ISO |
3 |
49,711,435 |
49,720,934 |
RGD:6480464 |
CTD |
| G |
APP |
amyloid beta (A4) precursor protein |
|
increases secretion |
EXP |
21 |
27,252,861 |
27,543,446 |
RGD:6480464 |
CTD |
| G |
APP |
amyloid beta (A4) precursor protein |
|
increases secretion |
ISO |
21 |
27,252,861 |
27,543,446 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
EXP |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
multiple interactions |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BCHE |
butyrylcholinesterase |
|
decreases activity |
ISO |
3 |
165,490,692 |
165,555,253 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
11 |
104,896,235 |
104,905,884 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
decreases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
increases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
increases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
decreases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CES2 |
carboxylesterase 2 |
|
increases expression |
ISO |
16 |
66,968,347 |
66,978,999 |
RGD:6480464 |
CTD |
| G |
CHAT |
choline O-acetyltransferase |
|
increases activity |
ISO |
10 |
50,817,141 |
50,873,150 |
RGD:6480464 |
CTD |
| G |
CHRM1 |
cholinergic receptor, muscarinic 1 |
|
decreases expression |
ISO |
11 |
62,676,151 |
62,689,012 |
RGD:6480464 |
CTD |
| G |
CHRM2 |
cholinergic receptor, muscarinic 2 |
|
decreases expression |
ISO |
7 |
136,553,399 |
136,701,771 |
RGD:6480464 |
CTD |
| G |
CHRM3 |
cholinergic receptor, muscarinic 3 |
|
decreases expression |
ISO |
1 |
239,792,373 |
240,072,720 |
RGD:6480464 |
CTD |
| G |
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
EXP |
20 |
61,974,662 |
61,992,748 |
RGD:6480464 |
CTD |
| G |
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
EXP |
1 |
154,540,257 |
154,552,354 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
decreases activity |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
decreases phosphorylation |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CYBB |
cytochrome b-245, beta polypeptide |
|
increases expression |
ISO |
X |
37,639,270 |
37,672,714 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
affects localization |
ISO |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
affects localization |
ISO |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
ISO |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
increases activity |
ISO |
9 |
136,501,485 |
136,524,466 |
RGD:6480464 |
CTD |
| G |
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
multiple interactions |
ISO |
9 |
136,501,485 |
136,524,466 |
RGD:6480464 |
CTD |
| G |
DRD2 |
dopamine receptor D2 |
|
decreases activity |
ISO |
11 |
113,280,317 |
113,346,001 |
RGD:6480464 |
CTD |
| G |
DRD2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
11 |
113,280,317 |
113,346,001 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
decreases activity |
EXP |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
|
decreases expression |
ISO |
1 |
1,950,768 |
1,962,192 |
RGD:6480464 |
CTD |
| G |
GCK |
glucokinase (hexokinase 4) |
|
decreases activity |
ISO |
7 |
44,183,870 |
44,229,022 |
RGD:6480464 |
CTD |
| G |
GCK |
glucokinase (hexokinase 4) |
|
increases expression |
ISO |
7 |
44,183,870 |
44,229,022 |
RGD:6480464 |
CTD |
| G |
GNLY |
granulysin |
|
decreases expression |
EXP |
2 |
85,921,414 |
85,925,875 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases activity |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases activity |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases expression |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
decreases activity |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GYS2 |
glycogen synthase 2 (liver) |
|
increases activity |
ISO |
12 |
21,689,123 |
21,757,781 |
RGD:6480464 |
CTD |
| G |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
decreases expression |
EXP |
5 |
54,398,474 |
54,406,080 |
RGD:6480464 |
CTD |
| G |
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
decreases expression |
EXP |
14 |
25,100,160 |
25,103,432 |
RGD:6480464 |
CTD |
| G |
GZMK |
granzyme K (granzyme 3; tryptase II) |
|
decreases expression |
EXP |
5 |
54,320,107 |
54,329,960 |
RGD:6480464 |
CTD |
| G |
HDC |
histidine decarboxylase |
|
increases activity |
ISO |
15 |
50,534,144 |
50,558,162 |
RGD:6480464 |
CTD |
| G |
HK1 |
hexokinase 1 |
|
decreases activity |
ISO |
10 |
71,029,756 |
71,161,638 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
decreases expression |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases secretion |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
decreases response to substance |
ISO |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
increases expression |
ISO |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
increases expression |
ISO |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
LCAT |
lecithin-cholesterol acyltransferase |
|
decreases activity |
EXP |
16 |
67,973,787 |
67,978,015 |
RGD:6480464 |
CTD |
| G |
LCAT |
lecithin-cholesterol acyltransferase |
|
multiple interactions |
EXP |
16 |
67,973,787 |
67,978,015 |
RGD:6480464 |
CTD |
| G |
LPL |
lipoprotein lipase |
|
decreases activity |
ISO |
8 |
19,796,582 |
19,824,770 |
RGD:6480464 |
CTD |
| G |
MAOA |
monoamine oxidase A |
|
decreases activity |
ISO |
X |
43,514,155 |
43,606,071 |
RGD:6480464 |
CTD |
| G |
MAOB |
monoamine oxidase B |
|
decreases activity |
ISO |
X |
43,625,857 |
43,741,721 |
RGD:6480464 |
CTD |
| G |
MAP2 |
microtubule-associated protein 2 |
|
increases phosphorylation |
ISO |
2 |
210,288,771 |
210,598,834 |
RGD:6480464 |
CTD |
| G |
MAP2 |
microtubule-associated protein 2 |
|
multiple interactions |
ISO |
2 |
210,288,771 |
210,598,834 |
RGD:6480464 |
CTD |
| G |
MAP2 |
microtubule-associated protein 2 |
|
increases phosphorylation |
ISO |
2 |
210,288,771 |
210,598,834 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
NCEH1 |
neutral cholesterol ester hydrolase 1 |
|
affects expression |
ISO |
3 |
172,348,435 |
172,429,008 |
RGD:6480464 |
CTD |
| G |
NCEH1 |
neutral cholesterol ester hydrolase 1 |
|
decreases activity |
ISO |
3 |
172,348,435 |
172,429,008 |
RGD:6480464 |
CTD |
| G |
NEFL |
neurofilament, light polypeptide |
|
decreases expression |
ISO |
8 |
24,808,468 |
24,814,131 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
increases activity |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
PNPLA6 |
patatin-like phospholipase domain containing 6 |
|
decreases activity |
ISO |
19 |
7,599,038 |
7,626,653 |
RGD:6480464 |
CTD |
| G |
PNPLA6 |
patatin-like phospholipase domain containing 6 |
|
decreases activity |
ISO |
19 |
7,599,038 |
7,626,653 |
RGD:6480464 |
CTD |
| G |
PNPLA6 |
patatin-like phospholipase domain containing 6 |
|
decreases activity |
ISO |
19 |
7,599,038 |
7,626,653 |
RGD:6480464 |
CTD |
| G |
PNPLA6 |
patatin-like phospholipase domain containing 6 |
|
decreases activity |
EXP |
19 |
7,599,038 |
7,626,653 |
RGD:6480464 |
CTD |
| G |
PNPLA6 |
patatin-like phospholipase domain containing 6 |
|
decreases activity |
ISO |
19 |
7,599,038 |
7,626,653 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
PON1 |
paraoxonase 1 |
|
multiple interactions |
ISO |
7 |
94,927,669 |
94,953,884 |
RGD:6480464 |
CTD |
| G |
PON1 |
paraoxonase 1 |
|
decreases response to substance |
ISO |
7 |
94,927,669 |
94,953,884 |
RGD:6480464 |
CTD |
| G |
PRF1 |
perforin 1 (pore forming protein) |
|
decreases expression |
EXP |
10 |
72,357,104 |
72,362,531 |
RGD:6480464 |
CTD |
| G |
PYGB |
phosphorylase, glycogen; brain |
|
increases activity |
ISO |
20 |
25,228,706 |
25,278,648 |
RGD:6480464 |
CTD |
| G |
PYGL |
phosphorylase, glycogen, liver |
|
increases activity |
ISO |
14 |
51,371,935 |
51,411,248 |
RGD:6480464 |
CTD |
| G |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
90,645,250 |
90,759,447 |
RGD:6480464 |
CTD |
| G |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects localization |
ISO |
4 |
90,645,250 |
90,759,447 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
TAP1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
increases expression |
ISO |
6 |
32,812,986 |
32,821,748 |
RGD:6480464 |
CTD |
| G |
TAT |
tyrosine aminotransferase |
|
multiple interactions |
ISO |
16 |
71,600,754 |
71,610,998 |
RGD:6480464 |
CTD |
| G |
TAT |
tyrosine aminotransferase |
|
increases expression |
ISO |
16 |
71,600,754 |
71,610,998 |
RGD:6480464 |
CTD |
| G |
TF |
transferrin |
|
affects binding |
EXP |
3 |
133,464,977 |
133,497,850 |
RGD:6480464 |
CTD |
| G |
TF |
transferrin |
|
affects binding |
ISO |
3 |
133,464,977 |
133,497,850 |
RGD:6480464 |
CTD |
| G |
TH |
tyrosine hydroxylase |
|
increases activity |
ISO |
11 |
2,185,159 |
2,193,035 |
RGD:6480464 |
CTD |
| G |
TH |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
11 |
2,185,159 |
2,193,035 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
increases secretion |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases expression |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TUBB |
tubulin, beta class I |
|
increases phosphorylation |
ISO |
6 |
30,688,157 |
30,693,199 |
RGD:6480464 |
CTD |
| G |
TUBB |
tubulin, beta class I |
|
increases phosphorylation |
ISO |
6 |
30,688,157 |
30,693,199 |
RGD:6480464 |
CTD |
| G |
UGP2 |
UDP-glucose pyrophosphorylase 2 |
|
decreases activity |
ISO |
2 |
64,068,098 |
64,118,696 |
RGD:6480464 |
CTD |
Term paths to the root
|